MapLight Therapeutics, Inc.

NASDAQ:MPLT

Biotechnology

Healthcare
$6.65 +3.11%

+$0.39 today

Market cap
$283.41M
Beta
2.65
P/E (TTM)
-2.8
EPS (TTM)
-$4.41
52W Low $9.10High $40.43

Volume 0.42M

Average 0.73M

MPLT EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How MPLT compares with its peers on the latest reported figures

MPLT Competitors Peer median
EBITDA Margin for MPLT and competitors
Company Period LTM level YoY 3-year change
ZVRAZevra Therapeutics, Inc.LTM Mar 2026114.9% +263.4 pp+343.9 pp
OVIDOvid Therapeutics Inc.LTM Mar 2026-337.0% +4411.9 pp+3368.5 pp
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026-590.7% ——
MPLTMapLight Therapeutics, Inc.FY2025— ——
DFTXDefinium Therapeutics, Inc.FY2025— ——
LBRXLB Pharmaceuticals Inc Common StockFY2025— ——
GHRSGH Research PLCFY2025— ——
ANROAlto Neuroscience, Inc.FY2025— ——
NERVMinerva Neurosciences, Inc.FY2025— ——
AVXLAnavex Life Sciences Corp.FY2025— ——
NMRANeumora Therapeutics, Inc. Common StockFY2025— ——
Peer median (excluding MPLT) -337.0%+2337.7 pp+1856.2 pp

Competitors are the stored peer set for MPLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000
Cost of Revenue574K556K701K578K
Gross Profit(574K)(556K)(701K)(578K)
Gross Margin————
Research & Development26.57M49.12M67.82M137.77M
Selling, General & Admin4.1M7.61M14.42M30.73M
Operating Expenses30.67M56.73M82.25M168.51M
Depreciation & Amortization574K556K701K578K
EBITDA(29.44M)(55.15M)(76.88M)(160.57M)
EBITDA Margin————
Operating Income(31.25M)(57.28M)(82.95M)(169.08M)
Operating Margin————
Interest Income429K1.1M4.5M5.52M
Interest Expense0000
Other Income / Expenses1.23M1.57M5.37M7.93M
Income Before Tax(30.02M)(55.71M)(77.58M)(161.15M)
Pre-Tax Margin————
Income Tax Expense0000
Net Income(30.02M)(55.71M)(77.58M)(161.15M)
Net Margin————
EPS (Basic)(0.72)(1.34)(1.87)(3.66)
EPS (Diluted)(0.72)(1.34)(1.87)(3.66)
Weighted Avg Shares41.43M41.43M41.43M44.02M
Weighted Avg Shares (Diluted)41.43M41.43M41.43M44.02M

MapLight Therapeutics, Inc.

NASDAQ:MPLT

Intrinsic Alpha fair value

Locked

Current Price

$6.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.